What is Zacks Small Cap’s Estimate for ADAP Q1 Earnings?
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Analysts at Zacks Small Cap issued their Q1 2025 EPS estimates for Adaptimmune Therapeutics in a report released on Tuesday, March 25th. Zacks Small Cap analyst M. Kim forecasts that the biotechnology company will post earnings of ($0.23) per share for the quarter. The consensus estimate for […]
